Andrew Cooper
Stock Analyst at Raymond James
(3.11)
# 1,185
Out of 5,134 analysts
151
Total ratings
44.78%
Success rate
0.99%
Average return
Main Sectors:
Stocks Rated by Andrew Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AZTA Azenta | Maintains: Outperform | $35 → $45 | $28.62 | +57.23% | 3 | Nov 25, 2025 | |
| ITGR Integer Holdings | Reiterates: Outperform | $143 → $95 | $85.92 | +10.57% | 4 | Oct 24, 2025 | |
| HOLX Hologic | Downgrades: Market Perform | n/a | $75.06 | - | 13 | Oct 22, 2025 | |
| AVTR Avantor | Maintains: Outperform | $14 → $16 | $9.20 | +73.91% | 16 | Oct 16, 2025 | |
| HAE Haemonetics | Downgrades: Outperform | $105 → $78 | $57.76 | +35.04% | 10 | Aug 11, 2025 | |
| GH Guardant Health | Maintains: Outperform | $59 → $61 | $104.85 | -41.82% | 4 | Jul 31, 2025 | |
| RVTY Revvity | Reiterates: Outperform | $120 → $115 | $96.03 | +19.75% | 9 | Jul 29, 2025 | |
| TMO Thermo Fisher Scientific | Reiterates: Outperform | $525 → $535 | $504.82 | +5.98% | 7 | Jul 24, 2025 | |
| MYGN Myriad Genetics | Reiterates: Outperform | $19 → $10 | $4.49 | +122.72% | 5 | May 7, 2025 | |
| FLGT Fulgent Genetics | Reiterates: Outperform | $24 → $25 | $23.43 | +6.70% | 2 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $245.81 | - | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $212.58 | - | 8 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $103.24 | - | 8 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $19.63 | - | 16 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $68 → $85 | $206.23 | -58.78% | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $100 → $76 | $23.58 | +222.31% | 12 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $4.24 | - | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $11.39 | - | 14 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $35.80 | - | 8 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $2.76 | - | 5 | Sep 22, 2021 |
Azenta
Nov 25, 2025
Maintains: Outperform
Price Target: $35 → $45
Current: $28.62
Upside: +57.23%
Integer Holdings
Oct 24, 2025
Reiterates: Outperform
Price Target: $143 → $95
Current: $85.92
Upside: +10.57%
Hologic
Oct 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $75.06
Upside: -
Avantor
Oct 16, 2025
Maintains: Outperform
Price Target: $14 → $16
Current: $9.20
Upside: +73.91%
Haemonetics
Aug 11, 2025
Downgrades: Outperform
Price Target: $105 → $78
Current: $57.76
Upside: +35.04%
Guardant Health
Jul 31, 2025
Maintains: Outperform
Price Target: $59 → $61
Current: $104.85
Upside: -41.82%
Revvity
Jul 29, 2025
Reiterates: Outperform
Price Target: $120 → $115
Current: $96.03
Upside: +19.75%
Thermo Fisher Scientific
Jul 24, 2025
Reiterates: Outperform
Price Target: $525 → $535
Current: $504.82
Upside: +5.98%
Myriad Genetics
May 7, 2025
Reiterates: Outperform
Price Target: $19 → $10
Current: $4.49
Upside: +122.72%
Fulgent Genetics
May 5, 2025
Reiterates: Outperform
Price Target: $24 → $25
Current: $23.43
Upside: +6.70%
Mar 28, 2025
Initiates: Market Perform
Price Target: n/a
Current: $245.81
Upside: -
Feb 3, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $212.58
Upside: -
Sep 26, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $103.24
Upside: -
May 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $19.63
Upside: -
Feb 20, 2024
Downgrades: Outperform
Price Target: $68 → $85
Current: $206.23
Upside: -58.78%
Feb 14, 2024
Downgrades: Outperform
Price Target: $100 → $76
Current: $23.58
Upside: +222.31%
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $4.24
Upside: -
May 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $11.39
Upside: -
Jan 18, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $35.80
Upside: -
Sep 22, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $2.76
Upside: -